Adaptation in neonatology of the once-daily concept of aminoglycoside administration: Evaluation of a dosing chart for amikacin in an intensive care unit

Biology of the Neonate

Volumn 74, Issue 5, 1998, Pages 351-362

  Langhendries, J P ^a   Battisti, O ^b   Bertrand, J M ^b   Francois A ^b   Kalenga, M ^b   Darimont, J ^b   Scalais, E ^b   Wallemacq, P ^b  

^a NICU   (Belgium)

^b NONE

Author keywords

Amikacin; Aminoglycosides; Brainstem auditory evoked potentials; Dosing chart; Neonates; Nephrotoxicity; Ototoxicity; Pharmacokinetics; Preterm

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CREATININE; INDOMETACIN;

ARTICLE; ASPHYXIA; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG UPTAKE; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOXIA; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; NEWBORN; NEWBORN INTENSIVE CARE; OTOTOXICITY; PRIORITY JOURNAL; SEPTIC SHOCK; STREPTOCOCCUS AGALACTIAE;

AMINOGLYCOSIDES; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVALUATION STUDIES; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTION; INTENSIVE CARE UNITS, NEONATAL; KIDNEY; MALE; MEDICAL RECORDS; NEONATOLOGY; OSMOLAR CONCENTRATION; PROSPECTIVE STUDIES;

EID: 0031655808     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014053     Document Type: Article

References (37)

1. Mattie H: The importance of pharmacokinetics and pharmacodynamics for effective treatment of infections. Clin Invest 1993;71:480-482.
2. Cars O: Pharmacokinetics of antibiotics in tissues and tissue fluids: A review. Scand J Infect Dis 1991; 74(suppl):23-33.
3. Craig WA, Ebert SC: Killing and regrowth of bacteria in vitro: A review, Scand J Infect Dis 1991; 74(suppl):63-70.
4. Moore RD, Lietman PS, Smith CR: Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-99.
5. Mattie H, Craig WA, Pechere JD: Determinants of efficacy and toxicity of aminoglycosides. J Antimicrob Chemother 1989;24:281-293.
6. Craig WA, Gudmundsson S: The postantibiotic effect; in Lorian V (ed): Antibiotics in Laboratory Medicine. ed 2. Baltimore, Williams & Wilkias, 1986, pp 515-536.
7. MacKenzie FM, Gould IM: The post-antibiotic effect: Review, J Antimicrob Chemother 1993;32:519-537.
8. Chopra I, Ball PR: Transport of antibiotics into bacteria. Adv Microb Physiol 1982;23:183-240.
9. Livermore DM: Antibiotic uptake and transport by bacteria. Scand J Infect Dis 1991;74(suppl): 15-22.
10. Drusano GL: Human pharmacodynamics of beta-lactams, aminoglycosides and their combination. Scand J Infect Dis 1991;74(suppl):235-248.
11. Mattie H, van Dokkum AM, Brus-Weijer L, Krul AM, van Strijen E: Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics. J Infect Dis 1990;162:717-722.
12. Roosendaal R, Bakker-Woudenberg LAJM, van den Berg JC. Michel MF: Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumonia in rats. J Infect Dis 1985;152:373-383.
13. Tulkens PM: Nephrotoxicity of aminoglycosides. Toxicol Lett 1989;46: 107-123.
14. Giuliano RA. Verpooten GA, Verbist L, Wedeen R, De Broe ME: In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. J Pharmacol Exp Ther 1986;236:470-475.
15. Williams PD, Bennett DB, Gleason CR, Hottendorf GH: Correlation between renal membrane binding and nephrotoxicity of aminoglycosides. Antimicrob Agents Chemother 1987;31:570-574.
16. Tran Ba Huy P, Bernard P, Schacht J: Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J Clin Invest 1986;77: 1492-1500.
17. Meyer RD: Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides. Am J Med 1986;8(suppl):119-125.
18. Brummett RE, Fox KE: Aminoglycoside-induced hearing loss in humans. Antimicrob Agents Chemother 1989;33:797-800.
19. Tulkens PM: Efficacy and safety of aminoglycosides once-a-day: Experimental and clinical data. Scand J Infect Dis 1991;74(suppl):249-257.
20. Marik PE. Lipman J, Kobilski S, Scribante J: A prospective randomized study comparing once versus twice-daily amikacin dosing in critically ill adult and paediatric patients. J Antimicrob Chemother 1991;28:753-764.
21. Van der Auwera P, Meunier F, Ibrahim S, Kaufman L, Derde MP, Tulkens PM: Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in the three divided doses to cancer patients with urinary tract infection. Antimicrob Agents Chemother 1991;35:640-647
22. Brace RA, Ross MG, Robillard JE: Fetal and Neonatal Body Fluids. Reproductive and Perinatal Medicine. New York, Perinatology Press, 1989, vol XI.
23. Arant BS: Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr 1978;92:705-712.
24. Kenyon CF, Knoppert DC, Lee SK, van den Berghe HM, Chance GW: Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant. Antimicrob Agents Chemother 1990;34:265-268.
25. Langhendries JP, Battisti O, Bertrand JM, Francois A, Darimont J, Ibrahim S, Tulkens PM, Bernard A, Buchet JP: Once-a-day administration of amikacin in neonates: Assessment of nephrotoxicity and ototoxicity. Dev Pharmacol Ther 1993; 20:220-230.
26. Langhendries JP, Battisti O, Bertrand JM, Francois A, Darimont J, Tulkens PM, Bernard A, Buchet JP, Scalais E, WallemacQ PE: Administration en dose unique journalière de l'Amikacine. Adaptation à la néonatologie pour des enfants traités avant le 3ième jour d'âge postnatal. Méd Mal Infect 1993;23:44-54.
27. Langhendries JP, Darimont J, Wallemacq P, Scalais E: Amikacine en dose unitaire en néonatologie: rythme optimal d'administration en fonction de l'âge gestationnel et de la pathologie. Lett Infect 1995;6:34-38.
28. Leal T, Parez JJ, Van Binst R, Wallemacq PE: Computerized approach to monitoring aminoglycosides. Clin Chem 1991;37:1415-1419.
29. Finnström O: Studies on maturity in newborn infants. IX. Further observations on the use of external characteristics in estimating gestational age. Acta Paediatr Scand 1977;66: 601-604.
30. Lubchenco LO, Hansman C, Boyd E: Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 1966;37:403-408.
31. Gould T, Roberts RJ: Therapeutic problems arising from the use of the intravenous route for drug administration. J Pediatr 1979;95:465-471.
32. Wahlefeld AW, Herz G, Bergmeyer HU: A completely enzymatic determination of creatinine in human sera or urine (abstract). Scand J Clin Lab Invest 1972;29(suppl 126):30.
33. Landers S, Berry PL, Kearns GL, Kaplan SL, Rudolph AJ: Gentamicin disposition and effect on development of renal function in the very low birth weight infant. Dev Pharmacol Ther 1984;7:285-302.
34. Pons G, d'Athis P, Rey E, de Lauture D, Richard MO, Badoual J, Olive G: Gentamicin monitoring in neonates. Ther Drug Monit 1988; 10:421-427.
35. Rudd PT, Hughes EA, Placzer MM, Hodes DT: Reference ranges for plasma creatinine during the first month of life. Arch Dis Child 1983; 58:212-215.
36. Stockard JE, Stockard JJ, Kleinberg F, Westmoreland BF: Prognostic value of brainstem auditory evoked potentials in neonates. Arch Neurol 1983;40:360-365.
37. Salamy A, Mendelson T, Tooley W: Developmental profiles for the brainstem auditory evoked potential. Early Hum Dev 1982;6:331-339.